HYSTEROSCOPIC MYOMECTOMY

Area of Science:

• Gynecology
• Minimally Invasive Surgery

Background:

• Leiomyomas, particularly submucosal fibroids, are prevalent pelvic tumors.
• These fibroids frequently cause abnormal uterine bleeding and infertility, significantly impacting women's health.
• Hysteroscopic myomectomy is the gold standard for managing symptomatic submucosal fibroids due to its high efficacy and safety profile.

Purpose of the Study:

• To provide a comprehensive overview of hysteroscopic myomectomy techniques for submucosal fibroids.
• To discuss the advancements contributing to improved safety and efficiency in the procedure.
• To highlight hysteroscopic myomectomy as the definitive treatment for symptomatic submucosal fibroids.

Main Methods:

• Review of established and emerging hysteroscopic myomectomy techniques.
• Discussion of technological advancements in hysteroscopy, including optics, fluid management, and tissue removal.
• Emphasis on the role of surgical training in procedural outcomes.

Main Results:

• Hysteroscopic myomectomy demonstrates high efficacy and safety in managing symptomatic submucosal fibroids.
• Technological innovations have progressively enhanced the precision and safety of the procedure.
• Improved surgical training correlates with better patient outcomes and procedural efficiency.

Conclusions:

• Hysteroscopic myomectomy remains the definitive treatment for symptomatic submucosal uterine fibroids.
• Ongoing advancements in surgical technology and dedicated training are crucial for optimizing patient care.
• The procedure offers a safe and effective solution for women experiencing abnormal bleeding and infertility due to fibroids.